Japan, Aug. 6 -- SENJU PHARMACEUT CO LTD has got intellectual property rights for 'LIQUID FORMULATION OF BRIMONIDINE.' Other related details are as follows:
Application Number: JP,2021-166183
Category (FI): A61K31/7084,A61P27/06,A61K47/34,A61K47/16,A61K47/18,A61K31/498,A61K9/08,A61P43/00,111,A61K31/714,A61P27/02,A61P43/00,121,C07D403/12,A61K31/4415,A61K31/355,A61K31/23,A61K31/197,A61K31/164
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 8, 2021
Publication Date: April 21, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
